Health
Inhaled corticosteroids may not increase COVID-19 mortality – News-Medical.Net
Inhaled corticosteroids (ICS) are the first line of treatment to counter the inflammatory pathology in several conditions, including asthma and chronic obstructive pulmonary disease (COPD). Now, a new study published in the journal The Lancet Respiratory Medi…
Inhaled corticosteroids (ICS) are the first line of treatment to counter the inflammatory pathology in several conditions, including asthma and chronic obstructive pulmonary disease (COPD). Now, a new study published in the journal The Lancet Respiratory Medicinein September 2020 reports on the actual role of ICS in reducing COVID-19 mortality.
Higher COVID-19 Risk with Underlying Illness
Earlier studies have demonstrated a clear link between the occurrence of moderate or severe COVID-19, requ…
-
General5 hours agoHow a fake expert crashed the World | The West Report
-
Business4 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General7 hours agoAlbanese beats drum on economy as trade clouds gather
-
General5 hours agoToo skewed, too gentlemanly | The Spectator Australia